Wide Ranks

AYTU

Aytu BioPharma, Inc.

1.62

Top Statistics
Market Cap 9 M Forward PE 3.86 Revenue Growth -41.50 %
Current Ratio 0.99 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -19.56 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.9720 Enterprise / Revenue 0.0730 Price To Sales Trailing12 Months 0.1230
Profitability
Profit Margins -19.56 % Operating Margins -4.45 %
Balance Sheet
Total Cash 20 M Total Cash Per Share 3.25 Total Debt 16 M
Total Debt To Equity 59.24 Current Ratio 0.99 Book Value Per Share 4.64
All Measures
Short Ratio 1045.00 % Message Board Id finmb_291629081 Shares Short Prior Month 262313
Return On Equity -0.4724 City Denver Uuid 887c97be-184b-3c68-ac18-63df37b78e4c
Previous Close 1.60 First Trade Date Epoch Utc 1 B Book Value 4.64
Beta -1.40 Total Debt 16 M Volume 34082
Price To Book 0.3491 Last Split Date 1 B Fifty Two Week Low 1.41
Total Cash Per Share 3.25 Total Revenue 81 M Shares Short Previous Month Date 1 B
Target Median Price 8.00 Max Age 86400 Recommendation Mean 2.00
Sand P52 Week Change 0.3133 Operating Margins -4.45 % Target Mean Price 8.00
Net Income To Common -15844000 Short Percent Of Float 0.0392 Implied Shares Outstanding 6 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 51020
Average Volume10days 51020 Total Cash 20 M Next Fiscal Year End 1 B
Revenue Per Share 14.63 Held Percent Insiders 0.0244 Ebitda Margins 7.55 %
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 1.60 Target Low Price 8.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 2.06 Open 1.60 Free Cashflow 4 M
State CO Dividend Yield 0.00 % Return On Assets -0.0106
Time Zone Short Name EST Trailing Eps -1.70 Day Low 1.52
Address1 Denver Corporate Center III Shares Outstanding 6 M Price Hint 4
Target High Price 8.00 Website https://aytubio.com 52 Week Change -0.2926
Average Volume 30156 Forward Eps 0.4200 Recommendation Key buy
Compensation As Of Epoch Date 1 B Quick Ratio 70.10 % Last Split Factor 1:20
Regular Market Day High 1.66 Is_sp_500 False Profit Margins -19.56 %
Debt To Equity 59.24 Fifty Two Week High 3.45 Day High 1.66
Shares Short 192761 Regular Market Open 1.60 Industry Key drug-manufacturers-specialty-generic
Earnings Growth 0.00 % Enterprise To Revenue 0.0730 Revenue Growth -41.50 %
Shares Percent Shares Out 0.0313 Operating Cashflow -1388000 Currency USD
Time Zone Full Name America/New_York Market Cap 9 M Is_nasdaq_100 False
Zip 80237 Quote Type EQUITY Industry Drug Manufacturers - Specialty & Generic
Long Name Aytu BioPharma, Inc. Regular Market Day Low 1.52 Held Percent Institutions 0.3404
Current Price 1.62 Address2 Suite 920 7900 East Union Avenue Enterprise To Ebitda 0.9720
Financial Currency USD Current Ratio 0.99 Gross Margins 68.29 %
Industry Disp Drug Manufacturers - Specialty & Generic Number Of Analyst Opinions 1 Country United States
Float Shares 4 M Two Hundred Day Average 2.66 Enterprise Value 5 M
Price To Sales Trailing12 Months 0.1230 Forward PE 3.86 Regular Market Volume 34082
Ebitda 6 M Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally.

The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years of age and above, and Cotempla XR-ODT for patients from six to seventeen years old.

It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency.

The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021.

Aytu BioPharma, Inc. is headquartered in Denver, Colorado.